{"id":"shuxinin-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Shuxinin is derived from traditional Chinese medicine principles and is formulated to invigorate blood flow and eliminate stagnation. It is used clinically to improve tissue perfusion, reduce inflammation, and alleviate pain associated with poor circulation and microvascular dysfunction. The exact molecular targets and mechanisms have not been fully characterized in Western pharmacological terms.","oneSentence":"Shuxinin is a traditional Chinese medicine injection that promotes blood circulation and removes blood stasis to alleviate pain and improve microcirculation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:08:02.000Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Cerebral infarction"},{"name":"Peripheral vascular disease"},{"name":"Pain relief associated with blood stasis"}]},"trialDetails":[{"nctId":"NCT04950790","phase":"PHASE4","title":"Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2018-04-01","conditions":"Acute Ischemic Stroke","enrollment":480}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":595852,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Shuxinin injection","genericName":"Shuxinin injection","companyName":"Peking University Third Hospital","companyId":"peking-university-third-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Shuxinin injection is being studied in a clinical trial for the treatment of acute ischemic stroke. The exact mechanism of Shuxinin injection is currently unknown.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}